About this trial

The study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population, and the negative impact of the global COVID-19 pandemic may be even higher in this vulnerable group. The information gained from this study may provide an opportunity to determine the self-reported COVID-19 specific psychological distress in AYA cancer survivors, and may lead to the development of a targeted intervention to improve physical and psychosocial health for AYA cancer patients and survivors.

Eligibility criteria

Qualifiers

Initial cancer diagnosis between the ages of 15 to 39

Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry

For questionnaire provision: confirmed alive at time of contact

Disqualifiers

Inability to complete questionnaires in English

Seen at MD Anderson for a second opinion or non-treatment related visit

Trial design

Treatments tested in this trial

  • Quality-of-Life Assessment
  • Survey Administration

Treatment groups

600 Participants
are divided into 1 treatment group

Locations

1
M D Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator